Burning Rock Biotech (BNR) Income Statement (2018 - 2024)
Annual Income Statement report data from Dec 31, 2018 to Dec 31, 2024 for Burning Rock Biotech (BNR) in CNY with ability to convert in USD.
All data is split-adjusted. You can find the most accurate data from the reports on the SEC official website. We recommend verify information using official company filings before making investment decisions.
| 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | |
|---|---|---|---|---|---|---|---|
Revenue and COGS | |||||||
Total Revenue | 516M (-4.02%) | 537M (-4.58%) | 563M (+10.90%) | 508M (+18.13%) | 430M (+12.63%) | 382M (+82.74%) | 209M |
Cost Of Revenue | 153M (-11.93%) | 174M (-4.91%) | 183M (+27.47%) | 144M (+23.92%) | 116M (+7.05%) | 108M (+46.78%) | 74M |
Costof Goods And Services Sold | 153M (-11.93%) | 174M (-4.91%) | 183M (+27.47%) | 144M (+23.92%) | 116M (+7.05%) | 108M (+46.78%) | 74M |
Gross Profit | 362M (-0.23%) | 363M (-4.42%) | 380M (+4.36%) | 364M (+16.00%) | 314M (+14.85%) | 273M (+102.38%) | 135M |
Operating Expenses | |||||||
Research And Development | 232M (-33.06%) | 347M (-17.74%) | 422M (+14.68%) | 368M (+39.37%) | 264M (+68.18%) | 157M (+49.04%) | 105M |
Selling General And Administrative | 262M (-40.24%) | 438M (-22.96%) | 568M (+15.91%) | 490M (+66.87%) | 294M (+122.31%) | 132M (+49.67%) | 88M |
Operating Expenses | 494M (-37.07%) | 785M (-20.74%) | 990M (+15.39%) | 858M (+53.85%) | 558M (+92.93%) | 289M (+49.32%) | 194M |
Depreciation And Amortization | 52M (-60.87%) | 133M (+7.49%) | 124M (+159.79%) | 48M (+43.41%) | 33M (+6.22%) | 31M (+27.07%) | 25M |
Operating Income | |||||||
Operating Income | -357.56M (-46.58%) | -669.32M (-31.73%) | -980.41M (+23.00%) | -797.06M (+93.27%) | -412.40M (+143.89%) | -169.09M (+4.76%) | -161.40M |
Ebit | -357.56M (-46.58%) | -669.32M (-31.73%) | -980.41M (+23.00%) | -797.06M (+93.27%) | -412.40M (+143.89%) | -169.09M (+4.76%) | -161.40M |
EBITDA | -305.36M (-43.02%) | -535.92M (-37.42%) | -856.31M (+14.28%) | -749.30M (+97.65%) | -379.10M (+175.25%) | -137.73M (+0.74%) | -136.72M |
Other Income / Expenses | |||||||
Interest Expense | - | - | - | 1.54M (+129.85%) | 670K (-92.55%) | 8.99M (-49.92%) | 18M |
Net Interest Income | - | - | - | -1.54M (+129.85%) | -670.00K (-92.55%) | -8.99M (-49.92%) | -17.95M |
Net Income | |||||||
Income Tax Expense | 5.89M (+146.44%) | 2.39M (+20.10%) | 1.99M (+121.11%) | 900K | - | - | - |
Net Income From Continuing Operations | -346.63M (-46.97%) | -653.69M (-32.69%) | -971.23M (+21.91%) | -796.70M (+95.64%) | -407.23M (+140.74%) | -169.16M (-4.70%) | -177.50M |
Net Income | -346.63M (-46.97%) | -653.69M (-32.69%) | -971.23M (+21.91%) | -796.70M (+95.64%) | -407.23M (+140.74%) | -169.16M (-4.70%) | -177.50M |
Comprehensive Income Net Of Tax | -343.14M (-47.17%) | -649.50M (-30.15%) | -929.89M (+11.21%) | -836.18M (+43.15%) | -584.12M (+302.70%) | -145.05M (-20.05%) | -181.43M |